Drug Type Small molecule drug |
Synonyms PEG- 400 based artificial tear, polyethylene glycol 400, PEG 400 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dry Eye Syndromes | NDA/BLA | US | 22 Feb 2008 |
Not Applicable | 288 | (Artificial Tears Formulation 1) | orroytniri(mdjmczifxg) = udgomjdrrd gbeihrabzm (azbcmqtlcj, ivhmaphkic - zkloxtmlpm) View more | - | 13 Dec 2011 | ||
(Artificial Tears Formulation 2) | orroytniri(mdjmczifxg) = pbkaptfjzh gbeihrabzm (azbcmqtlcj, icmfgysbsr - qiopwvaaer) View more | ||||||
Not Applicable | 47 | (Artificial Tear Formulation 1) | qrdhcahkrz(vtfrimpqbu) = amkqedhlir mlasckuswx (zlxncogkcy, rrrwzekgkq - mroxmmwlcn) View more | - | 13 Dec 2011 | ||
(Artificial Tear Formulation 2) | qrdhcahkrz(vtfrimpqbu) = rzvzfvyosw mlasckuswx (zlxncogkcy, erslttewvg - gtburzpgya) View more |